These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21184934)

  • 1. Invited commentary.
    Gloviczki P
    J Vasc Surg; 2011 Jan; 53(1):137-8. PubMed ID: 21184934
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.
    Regan JD; Gibson KD; Rush JE; Shortell CK; Hirsch SA; Wright DD
    J Vasc Surg; 2011 Jan; 53(1):131-7. PubMed ID: 20864303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results.
    Kölbel T; Hinchliffe RJ; Lindblad B
    Phlebology; 2007; 22(5):219-22. PubMed ID: 18269073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited Commentary re: Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-blind Trial with 2 Year-Follow-up. "The 3/1 Study".
    Cavezzi A
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):730. PubMed ID: 17888692
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein With New Parameters of the Technique.
    Baeshko A; Shestak N; Korytko S
    Vasc Endovascular Surg; 2016 Nov; 50(8):528-533. PubMed ID: 27837181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications and side-effects of foam sclerotherapy.
    Guex JJ
    Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-shot scleroembolization: a new technique for the treatment of varicose veins disease of lower extremities. Preliminary results.
    Viani MP; Viani GM; Sergenti J
    Phlebology; 2014 Dec; 29(10):694-7. PubMed ID: 23934946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polidocanol (Varithena) for varicose veins.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):111-2. PubMed ID: 26218793
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
    Engelberger RP; Ney B; Clair M; Dabiri A; Alatri A; Mazzolai L; Kern P
    Vasa; 2016; 45(3):255-8. PubMed ID: 27129073
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of sclerotherapy in varicose veins-- prospective, blinded, placebo-controlled study.
    Kahle B; Leng K
    Dermatol Surg; 2004 May; 30(5):723-8; discussion 728. PubMed ID: 15099314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-center experience with foam sclerotherapy without ultrasound guidance for treatment of varicose veins.
    Uurto I; Hannukainen J; Aarnio P
    Dermatol Surg; 2007 Nov; 33(11):1334-9; discussion 1339. PubMed ID: 17958585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of rectal varices treated with endoscopic injection sclerotherapy].
    Zeniya A; Odashima M; Takahashi H; Ohkubo S; Masamune O
    Nihon Shokakibyo Gakkai Zasshi; 1997 Jan; 94(1):38-43. PubMed ID: 9028142
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".
    Hamel-Desnos C; Ouvry P; Benigni JP; Boitelle G; Schadeck M; Desnos P; Allaert FA
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):723-9; discussion 730. PubMed ID: 17884623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foam sclerotherapy for the treatment of superficial venous insufficiency.
    Gibson KD; Ferris BL; Pepper D
    Surg Clin North Am; 2007 Oct; 87(5):1285-95, xii-xiii. PubMed ID: 17936487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of right-to-left shunt in patients with symptomatic great saphenous incompetence and varicose veins.
    Wright DD; Gibson KD; Barclay J; Razumovsky A; Rush J; McCollum CN
    J Vasc Surg; 2010 Jan; 51(1):104-7. PubMed ID: 19837542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of sclerotherapy of varicose veins].
    Schadeck M
    Hautarzt; 2003 Nov; 54(11):1065-72. PubMed ID: 14593464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein.
    Shadid N; Ceulen R; Nelemans P; Dirksen C; Veraart J; Schurink GW; van Neer P; vd Kley J; de Haan E; Sommer A
    Br J Surg; 2012 Aug; 99(8):1062-70. PubMed ID: 22627969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.